Clinical characteristics and risk factors analysis of Clostridioides difficile infection in ulcerative colitis patients during biologic therapy
ObjectiveTo investigate the risk factors for Clostridioides difficile infection (CDI) in patients with ulcerative colitis (UC) during biologic therapy.MethodsPatients diagnosed with UC who received Infliximab (IFX) or Vedolizumab (VDZ) were enrolled. Their clinical characteristics and risk factors f...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2026-03-01
|
| סדרה: | Frontiers in Cellular and Infection Microbiology |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fcimb.2026.1803104/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|